On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today reported its financial results ...
Get insights on Alexandria Real Estate (ARE) after its Q3 2025 slump. Learn why the sell-off may be overdone & if now is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback